3,3',5-Triiodo-L-thyronine (sodium salt hydrate)
(Synonyms: 三碘代甲状腺素钠盐水合物; Triiodothyronine sodium hydrate; 3,3',5-Triiodo-L-thyronine sodium hydrate; T3 sodium hydrate) 目录号 : GC48395A thyroid hormone
Cas No.:345957-19-9
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
3,3',5-Triiodo-L-thyronine (T3) is a thyroid hormone.1 It is produced by 5'-monodeiodination of the prohormone thyroxine (T4) in various tissues, including liver and kidney. T3 is an agonist of thyroid hormone receptors TRα and TRβ (Kis = 2.3 nM for both) that modulates diverse biological properties, including metabolism, cardiac function, growth, and redox signaling.2,3,4,5 It also functions as an inhibitor of L-type amino acid transporter 1 (LAT1), inhibiting LAT1-mediated leucine uptake in HEK293 cells when used at a concentration of 10 µM.6
1.Larsen, P.R., Silva, J.E., and Kaplan, M.M.Relationships between circulating and intracellular thyroid hormones: Physiological and clinical implicationsEndocr. Rev.2(1)87-102(1981) 2.Shiohara, H., Nakamura, T., Kikuchi, N., et al.Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemiaBioorgan. Med. Chem.20(11)3622-3634(2012) 3.Cox, M.D., Dalal, S.S., Heard, C.R.C., et al.Metabolic rate and thyroid status in rats fed diets of different protein-energy value: The importance of free T3J. Nutri.114(9)1609-1616(1984) 4.Macchia, P.E., Takeuchi, Y., Kawai, T., et al.Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor αProc. Nat. Acad. Sci. U.S.A.98(1)349-354(2001) 5.Videla, L.A., Cornejo, P., Romanque, P., et al.Thyroid hormone-induced cytosol-to-nuclear translocation of rat liver Nrf2 is dependent on Kupffer cell functioningSci. World J.20121-11(2012) 6.Kongpracha, P., Nagamori, S., Wiriyasermkul, P., et al.Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)J. Pharmacol. Sci.133(2)96-102(2017)
Cas No. | 345957-19-9 | SDF | |
别名 | 三碘代甲状腺素钠盐水合物; Triiodothyronine sodium hydrate; 3,3',5-Triiodo-L-thyronine sodium hydrate; T3 sodium hydrate | ||
Canonical SMILES | IC1=C(OC2=CC(I)=C(O)C=C2)C(I)=CC(C[C@@H](C([O-])=O)N)=C1.[Na+].O | ||
分子式 | C15H11I3NO4•Na [XH2O] | 分子量 | 673 |
溶解度 | DMF: 0.25 mg/ml,DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml,DMSO: 1 mg/ml | 储存条件 | Store at -20°C,protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.4859 mL | 7.4294 mL | 14.8588 mL |
5 mM | 0.2972 mL | 1.4859 mL | 2.9718 mL |
10 mM | 0.1486 mL | 0.7429 mL | 1.4859 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。